• 814 Citations
  • 13 h-Index
20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplastic Stem Cells Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
HhAntag691 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 814 Citations
  • 13 h-Index
  • 24 Article
  • 2 Book
  • 1 Chapter
  • 1 Review article

Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models

Tu, M. J., Ho, P. Y., Zhang, Q. Y., Jian, C., Qiu, J. X., Kim, E., Bold, R. J., Gonzalez, F. J., Bi, H. & Yu, A., Feb 1 2019, In : Cancer Letters. 442, p. 82-90 9 p.

Research output: Contribution to journalArticle

Prodrugs
MicroRNAs
Pancreatic Neoplasms
Heterografts
gemcitabine

Organoid profiling identifies common responders to chemotherapy in pancreatic cancer

Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G. H., Miyabayashi, K., Young, C. M., Patel, H., Ma, M., Lacomb, J. F., Palmaira, R. L. D., Javed, A. A., Huynh, J. C., Johnson, M., Arora, K. & 50 othersRobine, N., Shah, M., Sanghvi, R., Goetz, A. B., Lowder, C. Y., Martello, L., Driehuis, E., Lecomte, N., Askan, G., Iacobuzio-Donahue, C. A., Clevers, H., Wood, L. D., Hruban, R. H., Thompson, E., Aguirre, A. J., Wolpin, B. M., Sasson, A., Kim, J., Wu, M., Bucobo, J. C., Allen, P., Sejpal, D. V., Nealon, W., Sullivan, J. D., Winter, J. M., Gimotty, P. A., Grem, J. L., Dimaio, D. J., Buscaglia, J. M., Grandgenett, P. M., Brody, J. R., Hollingsworth, M. A., O’kane, G. M., Notta, F., Kim, E., Crawford, J. M., Devoe, C., Ocean, A., Wolfgang, C. L., Yu, K. H., Li, E., Vakoc, C. R., Hubert, B., Fischer, S. E., Wilson, J. M., Moffitt, R., Knox, J., Krasnitz, A., Gallinger, S. & Tuveson, D. A., Sep 1 2018, In : Cancer Discovery. 8, 9, p. 1112-1129 18 p.

Research output: Contribution to journalArticle

Organoids
Pancreatic Neoplasms
Drug Therapy
Therapeutics
Precision Medicine
34 Citations

Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis

Roe, J. S., Hwang, C. I., Somerville, T. D. D., Milazzo, J. P., Lee, E. J., Da Silva, B., Maiorino, L., Tiriac, H., Young, C. M., Miyabayashi, K., Filippini, D., Creighton, B., Burkhart, R. A., Buscaglia, J. M., Kim, E., Grem, J. L., Lazenby, A. J., Grunkemeyer, J. A., Hollingsworth, M. A., Grandgenett, P. M. & 4 othersEgeblad, M., Park, Y., Tuveson, D. A. & Vakoc, C. R., Aug 24 2017, In : Cell. 170, 5, p. 875-888.e20

Research output: Contribution to journalArticle

Transcription
Pancreatic Neoplasms
Adenocarcinoma
Chemical activation
Neoplasm Metastasis
3 Citations

Phase II study of dovitinib in patients progressing on anti-vascular endothelial growth factor therapy

Semrad, T., Kim, E., Tanaka, M., Sands, J., Roberts, C., Burich, R. A., Li, Y., Gandara, D. R., Lara, P. N. & Mack, P., Jan 1 2017, In : Cancer Treatment and Research Communications. 10, p. 21-26 6 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor A
Fibroblast Growth Factors
Therapeutics
Neoplasms
Lymphopenia
4 Citations

A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer

Zhen, D. B., Griffith, K. A., Ruch, J. M., Camphausen, K., Savage, J. E., Kim, E., Sahai, V., Simeone, D. M. & Zalupski, M. M., Jul 21 2016, (Accepted/In press) In : Investigational New Drugs. p. 1-7 7 p.

Research output: Contribution to journalArticle

gemcitabine
Pancreatic Neoplasms
Maximum Tolerated Dose
Adenocarcinoma
Disease-Free Survival